PubMed · 9686997
The source did not provide an abstract. Follow the original record for more information.
Explore connections, maps & timelines
S M Wilkinson, M H Beck. 1998. Patch testing with budesonide.. https://doi.org/10.1111/j.1600-0536.1998.tb05830.x
Cite the original work for its findings. Save a collection to share your selection of sources.
KEEP EXPLORING
Used gasoline engine oils (UGEO) are carcinogenic and/or mutagenic in long-term studies and capable of increasing the number of mutagen- or carcinogen-DNA adducts when applied dermally to mice. The carcinogenic or mutagenic risk of UGEO has been attributed to the concentration of polycyclic aromatic compounds (PAC) that accumulate in the lubricating system during combustion of gasoline. When dermal exposure to UGEO takes place, the use of hand cleansers, solvent- or d-limonene-based, is commonly recommended for washing, In this study, female mice aged 4-6 wk (12-17 g) were utilized to evaluate the efficiency of kerosene, as solvent-based cleanser, to remove UGEO following dermal exposure. Using a 32P postlabeling technique, the total levels of DNA adducts in skin and lung were significantly increased in kerosene-treated mice. Application of UGEO followed by kerosene washing significantly decreased skin DNA adduct levels but increased lung adduct levels after 8 h. The observed lower DNA adduct skin levels may reflect greater UGEO skin penetration and absorption in the presence of kerosene cleanser.
Photodynamic therapy (PDT) is a novel treatment modality that produces local tissue necrosis with laser light after prior administration of a photosensitizing agent. We performed a study of topically applied 5-aminolevulinic acid (5-ALA) in the photodynamic treatment of women with high-grade cervical intraepithelial neoplasia (CIN) using fixed 5-ALA doses and application protocols derived from previous in vitro and in vivo results. Three to 5 hr prior to PDT, 10 ml of a 20% solution of 5-ALA was topically applied using a cervical cap. PDT was performed with irradiation of 100 J/cm2 at an irradiance of 100-150 mW/cm2 with an argon-ion-pumped dye laser at 635 nm. For the endocervix, a specifically designed cylindrical applicator was used. Ten treatment cycles of PDT using 5-ALA were performed in 7 patients with high-grade CIN. Non-thermal laser treatment with 100-150 mW/cm2 was well tolerated. Local toxicity was minor as several patients reported burning sensations and vaginal discharge, but no necrosis, sloughing or scarring occurred. After 3 months, a significant reduction in the size of the ectocervical CIN lesions was noted in only 3 patients, who underwent a second PDT cycle. However, no significant improvement in CIN lesions was noted since cold knife conization revealed persistent CIN in all 7 cases. Therefore, PDT after topical application of 5-ALA using an irradiation of 100 J/cm2 produces only minimal side effects. However, it does not appear to be effective in treating CIN.
Phospholipids, e.g. fluid-state EPC (l-alpha-phosphatidylcholine from egg yolk), may diffuse into the stratum corneum and enhance dermal and transdermal drug penetration, while many other phospholipids, e.g. gel-state DSPC (distearoylphosphatidyl choline), are not able to do this. These effects are suggested to be due to the interactions between the phospholipids and the skin lipid bilayers, and so an in vitro method was developed to evaluate the influence of phospholipids on the distribution of drugs to stratum corneum lipids. The distribution coefficients of estradiol, progesterone and propranolol between stratum corneum lipid liposomes (SCLLs) without phospholipids or with EPC, DSPC, SPC (l-alpha-phosphatidylcholine from soybean) or DOPE (dioleylphosphatidyl ethanolamine), and pH 7.4 buffer were determined. Fluid-state phospholipids in SCLLs increased the partitioning of drugs into SCLLs, while gel-state lipid, DSPC, did not. The increased distribution of drugs into the SCLLs was at least partially due to the increased fluidity of SCLL bilayers by phospholipids, which was shown using steady-state fluorescence anisotropy. This in vitro method enables screening of the effects of phospholipids and other permeation enhancers on stratum corneum bilayer fluidity and drug partitioning.